Wednesday 27 September

07.30-09.00             EDUCATION TRACK 5 : Infection diseases

CREATORS: Frederike Bemelman, Amsterdam, The Netherlands and Marina Berenguer, Valencia, Spain

CHAIRS: Alain Le Moine, Brussels, Belgium and Frederike Bemelman, Amsterdam, The Netherlands


  • Prophylaxis of infections in solid organ transplantation (including donor derived infections)
    Jay Alan Fishman, Boston, United States
  • Infectious diseases in the central nervous system of Solid Organ Transplant patients
    Peter Portegies, Amsterdam, The Netherlands
  • Fungal and Yeast Infections in SOT patients
    José María Aguado, Madrid, Spain
  • Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation
    Oriol Manuel, Lausanne, Switzerland


07.30-09.00             EDUCATION TRACK 6 : Allograft phenotype and clinical implications

CREATORS: Maarten Naesens, Leuven, Belgium and Marlies Reinders, Leiden, The Netherlands

CHAIRS: Lorna Marson, Edinburgh, United Kingdom and Marlies Reinders, Leiden, The Netherlands


  • Allo-immune responses: what a clinician should know
    Frans Claas, Leiden, The Netherlands
  • Rejection phenotypes across organs: revisiting the basics
    Chris Bellamy, Edinburgh, United Kingdom
  • How to integrate complex histological phenotypes in routine clinical decision making?    
    Daniel Serón, Barcelona, Spain
  • Time to make computer-assisted instead of eminence-based decisions?
    Alexandre Loupy, Paris, France


08.00-09.00             Full oral sessions

                                Brief oral sessions


09:10 - 10:40           STATE OF THE ART 7 | DONOR MANAGEMENT 

CREATORS: Arne Neyrinck, Leuven, Belgium and Jacques Pirenne, Leuven, Belgium

The pre-requisite for successful transplantation is the recruitment of organs of acceptable quality in order to limit the mortality on the waiting list and to guarantee optimal short- and long-term outcome. During the last years, we have experienced a renewed interest in strategies to optimize donor management, especially since liberalization of donor criteria has been introduced within the field.  In this session, we want to address the question if we can still extend the potential donor pool. Therefore the focus will be directed towards recent innovative approaches and towards potential risk factors that might limit further expansion.  The session wants to involve all professionals involved, including anaesthesiologists, intensivists, nurses, coordinators and transplant physicians.

CHAIR : Arne Neyrinck, Leuven, Belgium

Lectures :

  • How controlled is my DCD?
    Sophie Van Cromphaut, Leuven, Belgium
  • Should I perfuse my donor?
    Simon Messer, Cambridge, United Kingdom
  • Tribulation in designing donor intervention studies
    Claus Niemann, San Francisco, United States
  • How clean is my donor?
    Margaret Hannan, Dublin, Ireland



CREATORS: Frank Dor, London, United Kingdom and Gabriel Oniscu, Edinburgh, United Kingdom

Live donation has become normal practice in many countries. The successful expansion of the acceptance criteria for live kidney donors is now challenged by emerging evidence for an increased relative risk for the development of renal failure on the long run. In this context it is even more important how transplant professionals provide tailor made information and risk assessments. How can we ensure that donors understand the potential risk? Do we have a good screening tool to assess potential psychological risk for live donors? Can we step away from standardized surgical approaches for live donor nephrectomy or is a tailor made approach more desirable? And one of the burning questions in liver transplantation currently is: Should living liver donor transplantation be advocated above deceased donor liver Tx, as is usually the case in kidney Tx ? This session focuses on the balance between Pushing the limits in the context of potential short and long-term complications.

CHAIR : Barış Akin, Ankara, Turkey

Lectures :

  • To be or not to be a donor?  (How can we make sure potential donors understand the risks?)
    Aisling Courtney, Belfast, Ireland
  • Psychosocial evaluation of live donors - the need for a tool to determine psychological risk
    Fabienne Dobbels, Leuven, Belgium
  • Tailor Made Live Donor Nephrectomy: a conversation between 2 surgeons
    Frank Dor, London, United Kingdom and Gabriel Oniscu, Edinburgh, United Kingdom
  • Should live liver donor transplantation be advocated above deceased donor liver Tx?
    Yaman Tokat, Istanbul, Turkey



CREATORS: Lorna Marson, Edinburgh, United Kingdom and Olivier Thaunat, Lyon, France

Transplant rejection involves a coordinated attack of the graft by the innate and the adaptive immune systems of the recipient. Although direct visualization of this complex cellular interplay, made possible by recent technological progresses, has greatly improved our understanding of rejection pathophysiology, it has also led to unexpected observations. Indeed, like in other chronic inflammatory conditions, organized lymphoid tissue develops within allografts. This session will provide an update on cellular interactions in rejection and will discuss whether intragraft tertiary lymphoid organs contribute to graft rejection and/or tolerance.

CHAIRS: Henri Leuvenink, Groningen, The Netherlands and Wilson Wong, London, United Kingdom

Lectures :

  • Visualizing cell traficking underlying allosensitization by two-photon microscopy
    Menna Clatworthy, Cambridge, United Kingdom
  • T cell migration to vascularized transplants
    Fadi Lakkis, Pittsburgh, United States
  • Lymphoid neogenesis: a tribute to the travellers
    Nancy Ruddle, New Haven, United States
  • Intragraft tertiary lymphoid organs: friends and foes
    Olivier Thaunat, Lyon, France


11:00 - 13:00           PLENARY SESSION 4 | LEADERSHIP IN TRANSPLANTATION – Closing Event

CREATORS: Lorna Marson, Edinburgh, United Kingdom and Stefan Schneeberger, Innsbruck, Austria

Leadership is a key element in our professional lives, yet the attention to professionalism in this "sport" has not received much attention. Much of the potential in our professional environment could be mobilized by enhancing the understanding of the principles in modern leadership. In this final plenary session, which will be also a closing event celebration, you will hear from some great leaders from within and outside transplantation. They will discuss leadership styles and give their own stories of leadership. As per the tradition of the ESOT conference, you will also be presented with a summary often most exciting innovations that have been discussed during the Congress in this session.

CHAIRS: Thierry Berney, Geneva, Switzerland - ESOT CURRENT PRESIDENT and Stefan Schneeberger, Innsbruck, Austria - ESOT PRESIDENT ELECT


  • Clinical: What's hot!
    Dennis Hesselink, Rotterdam, The Netherlands
  • Basic Science: What's hot!
    Oriol Bestard, Barcelona, Spain
  • Leadership in transplantation!
    Dorry Lidor Segev, Baltimore, United States and Rob Montgomery, New York, United States
  • KEYNOTE Leadership
    Javier Solana, Madrid, Spain
  • Presidential address
    Stefan Schneeberger, Innsbruck, Austria